Brown Judy L
Known title: DirectorCIK: 0001355818
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Agilent to acquire Proscia for up to $270M. Agilent Technologies has agreed to acquire digital pathology specialist Proscia in a deal valued at up to $270 million. The move is designed to strengthen Agilent's position in AI-enabled diagnostics and scientific intelligence. Following the announcement, TD Cowen raised its price target for the stock to $196.
Transaction History
| BDC | ▲ Buy | Grant | 1,527 | $0 | 5/21/2026 | View on chart |
| A | ▲ Buy | Grant | 2,158 | $241K | 3/19/2026 | View on chart |
| A | ▼ Sell | Open Market | 8 | $904 | 6/18/2025 | View on chart |
| BDC | ▲ Buy | Grant | 1,385 | $0 | 5/22/2025 | View on chart |
| A | ▲ Buy | Grant | 1,677 | $183K | 5/21/2025 | View on chart |
| BDC | ▲ Buy | Grant | 1,554 | $0 | 5/23/2024 | View on chart |
| BDC | ▼ Sell | Gift | 400 | $0 | 12/14/2023 | View on chart |
| BDC | ▲ Buy | Grant | 1,690 | $0 | 5/25/2023 | View on chart |
| BDC | ▲ Buy | Grant | 2,655 | $0 | 5/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Belden faces scrutiny over Ruckus debt and production shifts
Recent discussions focus on whether Belden's acquisition of Ruckus Networks creates more financial risk than expected, with some analysts arguing the debt looks scarier than the numbers suggest. Separately, there is debate about if shifting production to India strengthens the company's long-term outlook. These topics add uncertainty to the stock, which is currently trading below its 52-week high.
Belden faces scrutiny over Ruckus debt and production shifts. Recent discussions focus on whether Belden's acquisition of Ruckus Networks creates more financial risk than expected, with some analysts arguing the debt looks scarier than the numbers suggest. Separately, there is debate about if shifting production to India strengthens the company's long-term outlook. These topics add uncertainty to the stock, which is currently trading below its 52-week high.